- Home
- APRE vs XELB Comparison
APRE vs XELB Comparison
Compare APRE & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- XELB
- Stock Information
- Founded
- APRE 2006
- XELB 2011
- Country
- APRE United States
- XELB United States
- Employees
- APRE N/A
- XELB N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- XELB Multi-Sector Companies
- Sector
- APRE Health Care
- XELB Miscellaneous
- Exchange
- APRE Nasdaq
- XELB Nasdaq
- Market Cap
- APRE 21.3M
- XELB 19.0M
- IPO Year
- APRE 2019
- XELB N/A
- Fundamental
- Price
- APRE $2.92
- XELB $0.69
- Analyst Decision
- APRE Strong Buy
- XELB
- Analyst Count
- APRE 2
- XELB 0
- Target Price
- APRE $15.50
- XELB N/A
- AVG Volume (30 Days)
- APRE 13.3K
- XELB 17.0K
- Earning Date
- APRE 11-07-2024
- XELB 12-03-2024
- Dividend Yield
- APRE N/A
- XELB N/A
- EPS Growth
- APRE N/A
- XELB N/A
- EPS
- APRE N/A
- XELB N/A
- Revenue
- APRE $1,310,839.00
- XELB $10,062,000.00
- Revenue This Year
- APRE $116.72
- XELB N/A
- Revenue Next Year
- APRE N/A
- XELB $82.99
- P/E Ratio
- APRE N/A
- XELB N/A
- Revenue Growth
- APRE 130.31
- XELB N/A
- 52 Week Low
- APRE $2.15
- XELB $0.58
- 52 Week High
- APRE $8.85
- XELB $1.70
- Technical
- Relative Strength Index (RSI)
- APRE 34.50
- XELB 36.91
- Support Level
- APRE $2.87
- XELB $0.67
- Resistance Level
- APRE $3.35
- XELB $0.85
- Average True Range (ATR)
- APRE 0.32
- XELB 0.03
- MACD
- APRE -0.12
- XELB -0.01
- Stochastic Oscillator
- APRE 4.50
- XELB 15.87
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About XELB Xcel Brands Inc.
Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.